A successful research collaboration between Element Six and Harvard University’s spin out, Quantum Diamond Technologies Inc, aims to disrupt the medical diagnostic market by revolutionising the early detection and treatment of diseases.QDTI is a start-up founded by researchers from Harvard University with the aim of leveraging the powerful properties of quantum spins in diamond to significantly improve the early detection of diseases. A close and long-standing collaboration with Element Six has been integral to the development of QDTI’s technology, which relies on a multilayer diamond material solution powered by nitrogen vacancy (NV) centres for enhanced sensing.Thanks to QDTI’s innovation, combined with Element Six’s diamond manufacturing and modification expertise, new, simpler methodologies for isolating and counting key
biomarkers at high sensitivity are now feasible, in smaller hardware systems with improved time to results. QDTI estimates that its platform could lead to at least a 90%
reduction in technician hands-on time as well as greatly reducing the volume of reagents and disposables required for processing the patient’s sample. The resulting benefit
will be faster diagnosis times for patients at significantly lower cost, as well as a more environment-friendly product.
